Literature DB >> 26757037

Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study.

Nan Wang1, Gilles Allali1, Chandrasekharan Kesavadas2, Mohan L Noone3, Vayyattu G Pradeep3, Helena M Blumen1,4, Joe Verghese1,4.   

Abstract

BACKGROUND: The contribution of cerebral small vessel disease to cognitive decline, especially in non-Caucasian populations, is not well established.
OBJECTIVE: We examined the relationship between cerebral small vessel disease and motoric cognitive risk syndrome (MCR), a recently described pre-dementia syndrome, in Indian seniors.
METHODS: 139 participants (mean age 66.6 ± 5.4 y, 33.1% female) participating in the Kerala-Einstein study in Southern India were examined in a cross-sectional study. The presence of cerebral small vessel disease (lacunar infarcts and cerebral microbleeds (CMB)) and white matter hyperintensities on MRI was ascertained by raters blinded to clinical information. MCR was defined by the presence of cognitive complaints and slow gait in older adults without dementia or mobility disability.
RESULTS: Thirty-eight (27.3%) participants met MCR criteria. The overall prevalence of lacunar infarcts and CMB was 49.6% and 9.4% , respectively. Lacunar infarcts in the frontal lobe, but no other brain regions, were associated with MCR even after adjusting for vascular risk factors and presence of white matter hyperintensities (adjusted Odds Ratio (aOR): 4.67, 95% CI: 1.69-12.94). Frontal lacunar infarcts were associated with slow gait (aOR: 3.98, 95% CI: 1.46-10.79) and poor performance on memory test (β: -1.24, 95% CI: -2.42 to -0.05), but not with cognitive complaints or non-memory tests. No association of CMB was found with MCR, individual MCR criterion or cognitive tests.
CONCLUSIONS: Frontal lacunar infarcts are associated with MCR in Indian seniors, perhaps, by contributing to slow gait and poor memory function.

Entities:  

Keywords:  Aging; cerebral small vessel diseases; cognition; frontal lobe; gait; lacunar infarct; magnetic resonance imaging; memory

Mesh:

Year:  2016        PMID: 26757037      PMCID: PMC5292924          DOI: 10.3233/JAD-150523

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  41 in total

1.  Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment.

Authors:  P W Schofield; K Marder; G Dooneief; D M Jacobs; M Sano; Y Stern
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

2.  Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait.

Authors:  Belinda Bilney; Meg Morris; Kate Webster
Journal:  Gait Posture       Date:  2003-02       Impact factor: 2.840

3.  Gait in elderly with cerebral small vessel disease.

Authors:  Karlijn F de Laat; Anouk G W van Norden; Rob A R Gons; Lucas J B van Oudheusden; Inge W M van Uden; Bastiaan R Bloem; Marcel P Zwiers; Frank-Erik de Leeuw
Journal:  Stroke       Date:  2010-06-24       Impact factor: 7.914

4.  Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts.

Authors:  B R Reed; J L Eberling; D Mungas; M Weiner; W J Jagust
Journal:  Arch Neurol       Date:  2001-03

Review 5.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

6.  Motoric cognitive risk syndrome and the risk of dementia.

Authors:  Joe Verghese; Cuiling Wang; Richard B Lipton; Roee Holtzer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-17       Impact factor: 6.053

7.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

8.  Relationship between cerebral microbleeds and cognitive function in lacunar infarct.

Authors:  Min Zhang; Maogang Chen; Qizhang Wang; Wenwei Yun; Zhizhong Zhang; Qin Yin; Qinsong Huang; Wusheng Zhu
Journal:  J Int Med Res       Date:  2013-02-06       Impact factor: 1.671

9.  Early cerebral small vessel disease and brain volume, cognition, and gait.

Authors:  Eric E Smith; Martin O'Donnell; Gilles Dagenais; Scott A Lear; Andreas Wielgosz; Mukul Sharma; Paul Poirier; Grant Stotts; Sandra E Black; Stephen Strother; Michael D Noseworthy; Oscar Benavente; Jayesh Modi; Mayank Goyal; Saima Batool; Karla Sanchez; Vanessa Hill; Cheryl R McCreary; Richard Frayne; Shofiqul Islam; Jane DeJesus; Sumathy Rangarajan; Koon Teo; Salim Yusuf
Journal:  Ann Neurol       Date:  2015-02       Impact factor: 10.422

Review 10.  Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.

Authors:  Raj N Kalaria
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

View more
  18 in total

1.  The association of anxio-depressive disorders and depression with motoric cognitive risk syndrome: results from the baseline assessment of the Canadian longitudinal study on aging.

Authors:  Harmehr Sekhon; Gilles Allali; Olivier Beauchet
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

Review 2.  Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging.

Authors:  Peter Toth; Stefano Tarantini; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-28       Impact factor: 4.733

3.  Non-memory subjective cognitive concerns predict incident motoric cognitive risk syndrome.

Authors:  C Nester; E Ayers; L Rabin; J Verghese
Journal:  Eur J Neurol       Date:  2020-05-19       Impact factor: 6.089

Review 4.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

5.  Frailty and Its Correlates in Adults With Late Life Depression.

Authors:  Patrick J Brown; Steven P Roose; Kaleigh R O'Boyle; Adam Ciarleglio; Benjamin Maas; Kay C Igwe; Sarah Chung; Stephanie Gomez; Maleeha Naqvi; Adam M Brickman; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2019-10-14       Impact factor: 4.105

6.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

7.  Motoric Cognitive Risk Syndrome and Falls Risk: A Multi-Center Study.

Authors:  Michele L Callisaya; Emmeline Ayers; Nir Barzilai; Luigi Ferrucci; Jack M Guralnik; Richard B Lipton; Petr Otahal; Velandai K Srikanth; Joe Verghese
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

8.  Cortical Thickness, Volume, and Surface Area in the Motoric Cognitive Risk Syndrome.

Authors:  Helena M Blumen; Emily Schwartz; Gilles Allali; Olivier Beauchet; Michele Callisaya; Takehiko Doi; Hiroyuki Shimada; Velandai Srikanth; Joe Verghese
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  White Matter Hyperintensities in Older Adults and Motoric Cognitive Risk Syndrome.

Authors:  Joanna L Mergeche; Joe Verghese; Gilles Allali; Cuiling Wang; Olivier Beauchet; V G Pradeep Kumar; P S Mathuranath; Jennifer Yuan; Helena M Blumen
Journal:  J Neuroimaging Psychiatry Neurol       Date:  2016-11-03

Review 10.  Brain imaging of locomotion in neurological conditions.

Authors:  Gilles Allali; Helena M Blumen; Hervé Devanne; Elvira Pirondini; Arnaud Delval; Dimitri Van De Ville
Journal:  Neurophysiol Clin       Date:  2018-10-25       Impact factor: 3.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.